ReviewAnnals of geriatric medicine and research2025
Evaluation of Activities of Daily Living: Current Insights and Future Horizons.
Review in Annals of geriatric medicine and research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- A phase 2 trial of burosumab for treatment of fibroblast growth factor-23-mediated hypophosphatemia in children and adults with fibrous dysplasia.Bone research · 2026Trial
- Article
- Observational
- Effects of Digital Cognitive Rehabilitation on Functional Performance After Stroke: A Systematic Review and Meta-Analysis of ADL and IADL Outcomes.Healthcare (Basel, Switzerland) · 2026Review
- The Role of Radial Shockwave Therapy in Reducing Spasticity and Improving Upper-Limb Function Following Stroke.Journal of clinical medicine · 2026Article
- Care of Older Adults as Nursing's Defining Ground: Leading the Transformation Toward Prevention-Focused and Autonomy-Promoting Healthcare Systems.Journal of advanced nursing · 2026Article
- Network-based identification of central ADL and IADL items in older adults living alone.BMC geriatrics · 2026Article
- A phase 2 trial of burosumab for treatment of fibroblast growth factor-23 mediated hypophosphatemia in children and adults with fibrous dysplasia.medRxiv : the preprint server for health sciences · 2025Article
- Effect of LokomatMedical sciences (Basel, Switzerland) · 2025Article
- Balance and Gait Disorders in the Aged Population. Causes, Assessment and Management: A Literature Review.Clinical interventions in aging · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Activities of daily living (ADL) assessments are crucial for evaluating functional independence and formulating care strategies for older adults. However, the existing tools encounter challenges, including cultural bias, subjectivity, and limited sensitivity to subtle changes in functional abilities. This review examines these limitations across basic, instrumental, and extended ADL categories and explores the integration of emerging technologies, such as artificial intelligence, sensor-based systems, and remote monitoring tools, to address these gaps. Technological advancements have the potential to enhance the accuracy, efficiency, and inclusivity of ADL assessment by providing objective data, supporting real-time evaluations, and enabling personalized care plans. By bridging the gap between traditional methods and innovative technologies, this review highlights a pathway for more equitable and effective assessments, ensuring that older adults across diverse contexts receive tailored support to maintain their independence and improve their quality of life.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.